Assessment of neutralizing antibody response as a correlate of protection against symptomatic SARS-CoV-2 infections after administration of two doses of the CoronaVac inactivated COVID-19 vaccine: A phase III randomized controlled trial

Autor: Chen, Xinhua, Meng, Xing, Wu, Qianhui, Lim, Wey Wen, Xin, Qianqian, Cowling, Benjamin J., Meng, Weining, Yu, Hongjie, Covasa, Dimas Tadeu
Zdroj: In Journal of Infection December 2024 89(6)
Databáze: ScienceDirect